Stock Events

Stock Events

Innoviva 

$22.57
52
-$0.08-0.35% Today

Statistics

Day High
22.84
Day Low
22.49
52W High
24.24
52W Low
16.67
Volume
9,180,569
Avg. Volume
-
Mkt Cap
1.67B
P/E Ratio
7.01
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Sep 15
$0.25
Jun 15
$0.25
Mar 15
$0.25
Dec 14
$0.25
Sep 14
$0.25
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.74
0.15
1.05
1.94
Expected EPS
0.39
Actual EPS
N/A

Financials

65.92%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
822.66MRevenue
542.33MNet Income

Analyst Ratings

40.5Average Price Target
The highest estimate is 46.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow INVA. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline, partner in respiratory products, also competes in overlapping market segments.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca competes in the respiratory and biopharmaceutical market, similar to Innoviva's interests.
Vertex Pharmaceuticals
VRTX
Mkt Cap107.83B
Vertex Pharmaceuticals is involved in treating cystic fibrosis, a respiratory condition, thus competing with Innoviva.
Biogen
BIIB
Mkt Cap27.62B
Biogen competes in the biopharmaceutical space with a focus on innovative therapies, overlapping with Innoviva's market.
Regeneron Pharmaceuticals
REGN
Mkt Cap73.54B
Regeneron Pharmaceuticals competes in the biopharmaceutical field, focusing on innovative drug development like Innoviva.
AMGEN
AMGN
Mkt Cap178B
Amgen operates in the biopharmaceutical sector, focusing on innovative treatments, competing with Innoviva.
Gilead Sciences
GILD
Mkt Cap163.4B
Gilead Sciences competes in the biopharmaceutical market with a focus on innovation and research, similar to Innoviva.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie operates in the biopharmaceutical field, with a focus on research-based pharmaceuticals, competing with Innoviva.
Merck
MRK
Mkt Cap277.02B
Merck & Co. competes in the pharmaceutical and biopharmaceutical sectors, focusing on innovative therapies.
Pfizer
PFE
Mkt Cap149.77B
Pfizer competes across various therapeutic areas, including respiratory diseases, overlapping with Innoviva's market interests.

About

There is no Profile data available for HVE.MU.
Show more...
CEO
Mr. Pavel Raifeld C.F.A.
Employees
127
Country
United States
ISIN
US45781M1018

Listings

MU
DE
HVE.MU
STU
DE
HVE.STU
XNAS
US
INVA
F
DE
HVE.F

0 Comments

Share your thoughts

FAQ

What is Innoviva stock price today?▼
The current price of INVA is $22.57 USD — it has decreased by -0.35% in the past 24 hours. Watch Innoviva stock price performance more closely on the chart.
What is Innoviva stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Innoviva stocks are traded under the ticker INVA.
Is Innoviva stock price growing?▼
INVA stock has fallen by -2.15% compared to the previous week, the month change is a -2.02% fall, over the last year Innoviva has showed a +20.55% increase.
What is Innoviva market cap?▼
Today Innoviva has the market capitalization of 1.67B
When is the next Innoviva earnings date?▼
Innoviva is going to release the next earnings report on May 13, 2026.
What were Innoviva earnings last quarter?▼
INVA earnings for the last quarter are 1.94 USD per share, whereas the estimation was 0.55 USD resulting in a +252.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Innoviva revenue for the last year?▼
Innoviva revenue for the last year amounts to 822.66M USD.
What is Innoviva net income for the last year?▼
INVA net income for the last year is 542.33M USD.
Does Innoviva pay dividends?▼
Yes, INVA dividends are paid quarterly. The last dividend per share was 0.25 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Innoviva have?▼
As of May 06, 2026, the company has 127 employees.
In which sector is Innoviva located?▼
Innoviva operates in the Health & Wellness sector.
When did Innoviva complete a stock split?▼
The last stock split for Innoviva was on June 17, 2013 with a ratio of 1:100.
Where is Innoviva headquartered?▼
Innoviva is headquartered in Burlingame, United States.